Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bigorgne

Showing results (111-120 of 113) with videos related to

Pageof 12
Sort By:
You have reached the last page of results.This site can display upto 113 results.
Journal of Experimental & Clinical Cancer Research : CR|December 7, 2023
Immune checkpoints are predominantly co-expressed by clonally expanded CD4<sup>+</sup>FoxP3<sup>+</sup> intratumoral T-cells in primary human cancersDelphine Bredel, Edi Tihic, Séverine Mouraud, et al.
Journal of Experimental & Clinical Cancer Research : CR|July 6, 2022
Safety, recommended dose, efficacy and immune correlates for nintedanib in combination with pembrolizumab in patients with advanced cancersCapucine Baldini, Francois-Xavier Danlos, Andreea Varga, et al.
Iscience|July 25, 2022
Neuropilin-1 cooperates with PD-1 in CD8<sup>+</sup> T cells predicting outcomes in melanoma patients treated with anti-PD1Julien Rossignol, Zakia Belaid, Guillemette Fouquet, et al.
Pageof 12

Showing results (111-120 of 113) with videos related to

Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 113 results.
Journal of Experimental & Clinical Cancer Research : CR|December 7, 2023
Immune checkpoints are predominantly co-expressed by clonally expanded CD4<sup>+</sup>FoxP3<sup>+</sup> intratumoral T-cells in primary human cancersDelphine Bredel, Edi Tihic, Séverine Mouraud, et al.
Journal of Experimental & Clinical Cancer Research : CR|July 6, 2022
Safety, recommended dose, efficacy and immune correlates for nintedanib in combination with pembrolizumab in patients with advanced cancersCapucine Baldini, Francois-Xavier Danlos, Andreea Varga, et al.
Iscience|July 25, 2022
Neuropilin-1 cooperates with PD-1 in CD8<sup>+</sup> T cells predicting outcomes in melanoma patients treated with anti-PD1Julien Rossignol, Zakia Belaid, Guillemette Fouquet, et al.
Pageof 12